Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
- CHF | -.--% | -.--% | -.--% |
Zusammensetzung des L&G Pharma Breakthrough UCITS ETF - USD
Zu einer Liste hinzufügen 0 ausgewählt |
Kurs
|
%
|
% 5 Tage
|
% 1. Jan.
|
Gewichtung
| |
---|---|---|---|---|---|---|
318.9 USD | -0.03% | +3.17% | +44.97% | 2,55% | ||
281.4 SEK | +0.21% | +2.93% | +5.39% | 2,55% | ||
3’245 JPY | +0.62% | +1.88% | +5.02% | 2,50% | ||
- AUD | -.--% | - | - | 2,48% | ||
0.214 EUR | -.--% | - | - | 2,48% | ||
- EUR | -.--% | - | - | 2,48% | ||
- AUD | -.--% | - | - | 2,48% | ||
- USD | -.--% | - | - | 2,48% | ||
- RUB | - | - | - | 2,48% | ||
21.1 CAD | -0.24% | - | - | 2,48% | ||
- CAD | -.--% | - | - | 2,48% | ||
- EUR | -.--% | - | - | 2,48% | ||
- GBX | -.--% | - | - | 2,48% | ||
- NOK | -.--% | - | - | 2,48% | ||
0.3938 CAD | -17.11% | - | - | 2,48% | ||
182.8 DKK | +17.14% | +17.59% | +3.01% | 2,41% | ||
222.5 USD | -0.29% | -1.35% | -14.00% | 2,40% | ||
6’627 JPY | -0.08% | +5.27% | -6.03% | 2,38% | ||
5’652 JPY | +1.69% | +6.42% | +45.97% | 2,37% | ||
1’791 DKK | -0.44% | +1.94% | -16.89% | 2,37% | ||
147.8 USD | -2.13% | -4.99% | -18.06% | 2,35% | ||
51.5 USD | -1.72% | +1.06% | +39.07% | 2,34% | ||
49.62 EUR | +0.45% | +3.72% | +1.62% | 2,33% | ||
107 USD | -0.97% | -0.40% | -13.07% | 2,31% | ||
47.44 USD | +0.93% | +16.34% | -6.15% | 2,29% | ||
2.058 CHF | +1.38% | +1.38% | -2.65% | 2,26% | ||
146.9 USD | -0.17% | -0.58% | -6.26% | 2,23% | ||
19.31 USD | -0.21% | -0.26% | -9.00% | 2,19% | ||
2’774 JPY | +0.95% | +4.66% | +17.03% | 2,12% | ||
606 JPY | 0.00% | +2.54% | -48.29% | 2,12% | ||
5’812 JPY | +3.10% | +15.11% | +8.80% | 1,89% | ||
6.125 USD | +0.74% | -0.81% | +1.84% | 1,88% | ||
0.925 USD | -2.41% | +8.47% | -32.90% | 1,46% | ||
Beschreibung
ISIN Code | IE00BF0H7608 |
---|---|
Verwaltungsgebühren | 0.49% |
Anlageklassen | |
Branche | |
Wert | |
Währung | |
Fondsgesellschaft | |
Basiswert | Solactive Pharma Breakthrough Value NTR Index - USD |
Merkmale
Gerichtsstand | |
Replikationsmethode | |
Replikationsmodell | |
Erstellungsdatum |
23.01.2018
|
Dividenden-Politik | |
Geographischer Fokus |
Entwicklungen der ausstehenden Beträge ( 31.05.2024 )
Volumen (EUR) | 17 M€ |
---|---|
Volumen 1M | 17 M€ |
Volumen 3M | 21 M€ |
Volumen 6M | 28 M€ |
Volumen 12M | 56 M€ |
- Börse
- ETF
- A2H9XR ETF
- Einzelwerte L&G Pharma Breakthrough UCITS ETF - USD